Singapore markets close in 5 hours 37 minutes
Straits Times Index
3,301.86 +8.93 (+0.27%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,512.45 +36.53 (+0.20%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,806.15 +589.52 (+0.93%) CMC Crypto 200
1,329.18 +52.20 (+4.09%)
Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.55B |
| Enterprise value | 2.14B |
| Trailing P/E | 23.35 |
| Forward P/E | 34.25 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.17 |
| Price/book (mrq) | 4.66 |
| Enterprise value/revenue | 4.44 |
| Enterprise value/EBITDA | 19.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.48 |
| 52-week change 3 | 5.47% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 34.28 |
| 52-week low 3 | 20.84 |
| 50-day moving average 3 | 23.88 |
| 200-day moving average 3 | 26.59 |
Share statistics
| Avg vol (3-month) 3 | 1.1M |
| Avg vol (10-day) 3 | 1.62M |
| Shares outstanding 5 | 104.11M |
| Implied shares outstanding 6 | 104.11M |
| Float 8 | 85.36M |
| % held by insiders 1 | 11.38% |
| % held by institutions 1 | 84.82% |
| Shares short (15 Apr 2024) 4 | 21.12M |
| Short ratio (15 Apr 2024) 4 | 24.85 |
| Short % of float (15 Apr 2024) 4 | 28.67% |
| Short % of shares outstanding (15 Apr 2024) 4 | 20.34% |
| Shares short (prior month 15 Mar 2024) 4 | 20.22M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.54% |
| Operating margin (ttm) | 20.09% |
Management effectiveness
| Return on assets (ttm) | 11.96% |
| Return on equity (ttm) | 21.91% |
Income statement
| Revenue (ttm) | 523.53M |
| Revenue per share (ttm) | 5.12 |
| Quarterly revenue growth (yoy) | 39.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 122.8M |
| Net income avi to common (ttm) | 117.2M |
| Diluted EPS (ttm) | 1.05 |
| Quarterly earnings growth (yoy) | 74.80% |
Balance sheet
| Total cash (mrq) | 410.76M |
| Total cash per share (mrq) | 3.94 |
| Total debt (mrq) | 76k |
| Total debt/equity (mrq) | 0.01% |
| Current ratio (mrq) | 5.18 |
| Book value per share (mrq) | 5.27 |
Cash flow statement
| Operating cash flow (ttm) | 124.84M |
| Levered free cash flow (ttm) | 123.86M |
© 2024 Yahoo. All rights reserved.